Efficacy of Rasonadi Churna on Hyperandrogenism in PCOS affecting menstrual irregularities.

Phase 2/3

Not yet recruiting

• Conditions: Menstrual Irregularities

• Registration Number: CTRI/2024/05/067094
• Lead Sponsor: Dr Rekha Chhagan Kuwar

Brief Summary

This study is randomized clinical controlled trial comparing the safety and efficacy of Rasonadi Churna on Hyperandrogenism in PCOC affecting Menstrual irregularities.

Combination of Rasonadi Churna, Dose of 5gm BD with anupan Go-ghruta orally for 3 Months of POCS patients.

Primary outcome will be evaluation of irregular interval of menstrual period during 3 Month and secondary outcome will be effect of Rasonadi Churna on Hyperandrogenism and Insulin resistance in 3 Months.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-20
• Last Update Posted: 2024-06-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

Married and Unmarried patients of PCOS with Rotterdam criteria.

Exclusion Criteria

• Patients having.
• Hypogonadotrophic hypogonadism.
• Premature ovarian failure.
• Congenital adrenal hyperplasia.
• Hyperprolactenemia.
• Thyroid abnormalities.
• Tuberculosis.
• Congenital anomalies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of Rasonadi Churna in terms of irregular interval of menstrual periods.	12 Weeks

Secondary Outcome Measures

Name	Time	Method
- To study the effect of Rasonadi Churna on hyperandrogenesim.	- To study the effect of Rasonadi Churna on hyperandrogenesim and insulin resistance.

Trial Locations

Locations (1)

OPD No 8 Streeroga & Prasutitantra; 🇮🇳 Mumbai, MAHARASHTRA, India

OPD No 8 Streeroga & Prasutitantra

🇮🇳Mumbai, MAHARASHTRA, India

Dr Rekha Chhagan Kuwar

Principal investigator

9405010769

dr.rekhakuwar@gmail.com